PUBLICATIONS

Kaartinen MT, Hang A, Barry A, Arora M, Heinonen S, Lundholm J, Hakkarainen A, Rissanen A, Kaprio J, Pietilainen K (2022). Matrisome alterations in in obesity – a transcriptomics study on weight-discordant monozygotic twins. Matrix Biology. 108, 1-19.

Al-Hameda, FS, Abu-Nadaa L, Rodan R, Sarrigiannidisb S, Ramirez-Garcialunac JL, Mousa H , ElkashtyaO, Goaa Q, Basiria T, Tran SD, Lordkipanidzé, Kaartinen MT, Badrana Z, Tamimi F (2021). Differences in platelet concentrate composition influence bone healing. J Clin Periodontol. Dec;48(12):1613-1623.

Al-Hameda, FS, Rodan R, Ramirez-Garcialunac JL, Elkashty O, Goaa Q, Al-Shahrani N, Tran SD, Lordkipanidzé M, Kaartinen MT, Badran Z, Tamimi F (2021). The effect of aging on the bone healing properties of blood plasma. Injury. Jul;52(7):1697-1708.

Kaartinen MT, Arora M, Heinonen S, Rissanen A, Kaprio J, Pietilainen K. Transglutaminases and obesity: association of F13A1 to adipocyte hypetrophy and adipose tissue inflammation. Int. J Med. Sci. 21(21):8289.

Kaartinen MT, Arora M, Heinonen S, Hang A, Barry A, Lundholm J, Hakkarainen A, Kaprio J, Pietilainen K (2021). F13A1 transglutaminase in human adipose tissue associated with weight gain, and inflammatory status of adipocytes. Int J Obesity 45(3):577-587.

Mansour A, Abu Nada L, Elhahad A, Mezour MA, Al-Subaie A, Mussa Hanan, Laurenti M, Kaartinen MT, Tamimi F (2021). Biomimetic concentrations of trace elements improve bone regenerative properties of dicalcium phosphate bioceramics. J Biomed Mater Res A. 109(5):666-681.

Sun H and Kaartinen MT (2020). Assessment of activities of TG1, TG2 and Factor XIII-A during osteoclastogenesis. Analytical Biochem. 591:113512.

Chicatun F, Muja N, Rezabiegi E, Kaartinen MT, McKee MD Showan N. Nazhat SN (2019) A bilayered dense collagen/chitosan hydrogel to model the osteochondral interface. Emergent Materials. 2: 245-262.

Mansour A, Abu Nada L, Al-Waeli H, Mezour MA, Al-Abdallah MN, Kinsella JM, Kort Mascort J, Henderson JE, Ramirez-Garcialuna JL, El-Kashty O, Taqi, D, Alageel O, Kaartinen MT, Tamimi F (2019). Bone extracts immunomodulate and enhance the regenerative performance of dicalcium phosphates bioceramics. Acta Biomaterialia. 89:343-358.

Sun H and Kaartinen MT (2018). Transglutaminases in monocytes and macrophages. Med Sci. 6(4).

Sun H and Kaartinen MT (2018). Transglutaminase activity regulates differentiation, migration and fusion of osteoclasts via affecting actin dynamics. J. Cell Phys. 233(9):7497-7513.

Mousa A, Cui C, Song A, Myneni VD, J. Li, Murshed M, Melino G, Kaartinen MT (2017). Transglutaminases Factor XIII-A and TG2 regulate resorption, adipogenesis and plasma fibronectin homeostasis in bone and bone marrow. Cell Death Diff. 24(5):844-854.

Hoac B, Nelea V, Jiang W, Kaartinen MT, McKee MD (2017) Mineralization-inhibiting effects of transglutaminase-crosslinked polymeric osteopontin. Bone. 101:37-48

Myneni VD, Kaartinen MT (2016). Factor XIII-A deficient mice show signs of metabolically healthy obesity on high fat diet. Sci Rep. 6:35574.

Myneni VD, Kaartinen MT (2015). Transglutaminase 2 - A novel inhibitor of adipogenesis. Cell Death & Dis. 6:e1868.

Wang S, Kaartinen MT (2015). Cellular Factor XIIIA transglutaminase localizes in caveolae and regulates caveolin-1 phosphorylation, homo-oligomerization and c-Src signaling in osteoblasts. J. Histochem Cytochem. 63(11):829-41.

Cui C, Kaartinen MT (2015). Monoamines serotonin, inhibit plasma fibronectin assembly into extracellular matrix by acting as a competitive inhibitor to its transglutaminase mediated crosslinking. Bone. 72:43-52.

Addison WN, Nelea V, Chicatun F, Chien Y-C, Vali H, Tran-Khanh N, Buschmann MD, Nazhat SN, Kaartinen MT, Vali H, Tecklenburg M, Franceschi RT and McKee MD (2015). Extracellular matrix mineralization in murine MC3T3-E1 osteoblast cultures: An ultrastructural, compositional and comparative analysis with mouse bone. Bone. 71C:244-256.

Dargahi M, Nelea V, Mousa A, Omanovic S, Kaartinen MT (2014) Electrochemical modulation of plasma fibronectin surface conformation enables filament formation and control of endothelial cell-surface interactions. RSC Adv. 4 (88): 47769 - 47780.

Myneni VD, Hitomi K, Kaartinen MT (2014). Factor XIII-A transglutaminase acts as a switch between preadipocyte proliferation and differentiation. Blood. 124(8):1344-53.

Wang S, Cui C, Hitomi K, Kaartinen MT (2014). Detyrosinated Glu-tubulin is a substrate for cellular Factor XIIIA transglutaminase in differentiating osteoblasts. Amino Acids. 46(6):1513-26.

Ka K, Nicolau B, Henderson M, Tran S, Kaartinen MT, Myneni VD, Rousseau M-C (2014). Circulating uncarboxylated osteocalcin and gingival crevicular fluid tumour necrosis factor-α in children. J. Clin. Periodont. 41(5):467-72.

Eckert R, Kaartinen MT, Nurminskaya M, Belkin A, Colak G, Johnson GCW, Mehta K (2014). Transglutaminase regulation of cell function. Physiol. Reviews. 94, 383-417.

Cui C, Wang S, Myneni VD, Hitomi K, Kaartinen MT (2014). Transglutaminase activity is required for stabilization and conversion of plasma FN into permanent osteoblast matrix. Bone 59, 127-138.

Javaid M, Kaartinen MT (2013) Mesenchymal stem cell-based bone tissue engineering. Review. Int. Dental Journal of Students’ Research.1 (3), 24-35.

Dastjerdi AK, Pagano M, McKee MD, Kaartinen MT and Barthelat F (2012). The cohesive behavior of soft biological "glues": Experiments and modeling. Acta Biomater. 8: 3349–3359.

Piercy-Kotb SA, Mousa A, Al-Jallad HF, Myneni VD, Chicatun F, Nazhat SN, Kaartinen MT (2012). Factor XIIIA expression and secretion in osteoblast cultures is regulated by extracellular collagen network and MAP kinase pathway. J Cell Physiol. 227(7):2936-46.